Summary

Now in its 13th year, Frontiers in Cancer Immunotherapy brings together leading researchers, clinicians, and industry innovators to explore the next generation of therapies that are transforming cancer treatment. The field of immuno-oncology has achieved remarkable breakthroughs over the past decade. Yet, many challenges remain—from understanding the biology of resistant tumor types to identifying novel therapeutic targets and strategies. This year’s symposium will showcase cutting-edge research and highlight promising approaches in areas such as cancer vaccines, bispecifics, modulation of the tumor microenvironment, AI-driven discovery of immunotherapy, and cell-based therapies for solid tumors.

In addition to keynote lectures and plenary talks, the program features industry updates, short talks selected from abstracts, and a panel discussion on moving discoveries from the bench to the clinic. Ample networking opportunities will give participants the chance to connect with peers, collaborators, and leaders shaping the future of cancer immunotherapy.

Join us in New York City to share knowledge, foster new collaborations, and be part of the conversation driving the next breakthroughs in cancer treatment.

Sponsors

Presented By

The Cancer and Signaling
Discussion Group

Lead Supporter

Registration

This event is open for registration.